Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes
CA 2385697 A1 · Owner: Genesignal. · Inventors: Al-Mahmood, Salman
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns a method for identifying genes coding for cell constituents involved in the regulation of angiogenesis characterised in that it comprises the following steps: (a) culturing endothelial cells on a protein of the extracellular matrix according to four types of different conditions: a reference condition a condition promoting angiogenesis, a condition inhibiting angiogenesis a control condition; (b) isolating the messenger RNA derived from the cultured cells according to the different conditions; (c) comparing qualitatively and/or quantitatively different mRNA populations so as to identify the mRNA's exclusively derived or in particularly large amounts, from cell …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 20, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 20, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 20, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.